Immunological effects of CpG ODN [CpG-containing oligodeoxynucleotides] administration to HIV uninfected and HIV infected patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs CpG-containing oligodeoxynucleotides; Hepatitis B vaccine
- Indications Hepatitis B
- Focus Pharmacodynamics
- 01 Oct 2008 Biomarkers information updated
- 30 Sep 2008 Planned end date (1 Oct 2007) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.